PubRank

G Basso

Author PubWeight™ 156.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The role of the anterior prefrontal cortex in human cognition. Nature 1999 4.25
2 Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998 3.91
3 Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008 3.23
4 Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection. Leukemia 2005 3.09
5 Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood 1997 2.40
6 Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 2005 1.90
7 Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 2009 1.86
8 Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia 2007 1.79
9 Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000 1.71
10 Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia 2011 1.67
11 Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation. Leukemia 1994 1.54
12 Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. Br J Haematol 1997 1.45
13 Early and rapid diagnosis of CMV infection by nonradioactive in situ hybridization in pediatric kidney transplant recipients. Nephron 1992 1.39
14 The calculating brain: an fMRI study. Neuropsychologia 2000 1.32
15 Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998 1.31
16 Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia 2007 1.27
17 Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. J Clin Oncol 1995 1.26
18 Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007 1.25
19 Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 1996 1.25
20 Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia 2009 1.24
21 Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia 2004 1.21
22 Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002 1.20
23 Neural correlates of imaginal aggressive behavior assessed by positron emission tomography in healthy subjects. Am J Psychiatry 2000 1.17
24 Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region. Cancer 1997 1.17
25 Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. Leukemia 2012 1.16
26 Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. Leukemia 2005 1.16
27 Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring. Leukemia 2003 1.16
28 Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group. Blood 1997 1.16
29 N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification. Tumori 1991 1.16
30 Cortical localization of reading in normal children: an fMRI language study. Neurology 2001 1.14
31 Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction. Leukemia 2008 1.13
32 MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol 1997 1.11
33 CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease. Leukemia 2004 1.09
34 Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis 2013 1.08
35 Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 1992 1.08
36 Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia. Leukemia 2008 1.07
37 BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression. Cell Death Dis 2012 1.04
38 Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 2005 1.04
39 DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4. Leukemia 2009 1.03
40 Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer 1995 1.03
41 Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood 1998 1.02
42 Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer 1996 1.01
43 Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups. J Clin Oncol 1997 1.00
44 Performance of personal inhalable aerosol samplers in very slowly moving air when facing the aerosol source. Ann Occup Hyg 2004 0.97
45 Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 1998 0.96
46 Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-Oncology. Bone Marrow Transplant 1998 0.96
47 Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification. Leukemia 2003 0.95
48 Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993 0.95
49 Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia 2000 0.94
50 Differential amygdala responses to winning and losing: a functional magnetic resonance imaging study in humans. Eur J Neurosci 2000 0.94
51 Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem 1999 0.94
52 Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. Leukemia 2011 0.93
53 Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica. J Clin Oncol 2001 0.93
54 Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Oncogene 1997 0.93
55 Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells. Leukemia 2011 0.92
56 Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 1999 0.90
57 A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12). Cancer Genet Cytogenet 1993 0.89
58 ICER expression inhibits leukemia phenotype and controls tumor progression. Leukemia 2008 0.88
59 Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Exp Hematol 1997 0.88
60 Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia 2000 0.88
61 Transient acute monoblastic leukemia with reciprocal (8;16)(p11;p13) translocation. Pediatr Hematol Oncol 1996 0.88
62 MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study. Leukemia 2011 0.88
63 Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia 1995 0.88
64 Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia 1994 0.87
65 Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. Oncogene 1993 0.87
66 A comparison between in vivo and ex vivo HR-MAS 1H MR spectra of a pediatric posterior fossa lesion. Int J Mol Med 2005 0.87
67 Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia. Leukemia 2013 0.87
68 Spatial extinction on double asynchronous stimulation. Neuropsychologia 1997 0.86
69 Expression of type I interferon receptor in solid tumors of childhood. Mod Pathol 1997 0.86
70 PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy. Leukemia 2009 0.86
71 Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol 1992 0.85
72 Cell adhesion molecule expression in cord blood CD34+ cells. Stem Cells 1998 0.85
73 Visual extinction as a spatio-temporal disorder of selective attention. Neuroreport 1998 0.85
74 AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells. Leukemia 2012 0.85
75 Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia. Leukemia 2011 0.85
76 The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia. Leukemia 2005 0.84
77 Comparative sequence analysis of incomplete DJH and TCR gene rearrangements in children with relapses of T-ALL. Leukemia 2005 0.84
78 Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors. Blood 2001 0.84
79 Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Haematologica 1998 0.84
80 Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia. J Exp Med 1987 0.84
81 c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood 1998 0.84
82 Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum Mol Genet 1994 0.83
83 Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia. Blood Cancer J 2013 0.83
84 Li-Fraumeni syndrome: a case report from Italy. Br J Cancer 1990 0.83
85 A novel variant translocation t(2;13) (p23;q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol 1990 0.83
86 CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer 2002 0.83
87 Lymphocytes subsets reference values in childhood. Cytometry A 2014 0.82
88 p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing. Diagn Mol Pathol 1993 0.82
89 17q21-qter trisomy is an indicator of poor prognosis in acute myelogenous leukemia. Cancer Genet Cytogenet 2001 0.82
90 Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia 1992 0.82
91 Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology 2000 0.82
92 Cytogenetic analysis of hepatoblastoma: hypothesis of cytogenetic evolution in such tumors and results of a multicentric study. Cancer Genet Cytogenet 1998 0.81
93 Cytochemical study of thymocytes and T lymphocytes. Br J Haematol 1980 0.81
94 Flow cytometry: its applications in hematology. Haematologica 1995 0.81
95 Immunohistochemical distribution of endothelin in biopsies of pediatric nephrotic syndrome. Am J Nephrol 1994 0.81
96 The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome. Leukemia 1997 0.80
97 High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias. Leukemia 2004 0.80
98 p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24. Leukemia 1995 0.80
99 Are genotypes of glutathione S-transferase superfamily a risk factor for childhood acute lymphoblastic leukemia? Results of an Italian case-control study. Leukemia 2007 0.80
100 Lack of p73 expression in mature B-ALL and identification of three new splicing variants restricted to pre B and C-ALL indicate a role of p73 in B cell ALL differentiation. Leukemia 2000 0.80
101 Molecular and immunological evidence of B-cell commitment in "null" acute lymphoblastic leukaemia. Int J Cancer 1986 0.80
102 Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 1994 0.80
103 Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene. Leukemia 1997 0.80
104 Microsatellite analysis in childhood acute lymphoblastic leukemia. Haematologica 1998 0.79
105 American cutaneous leishmaniasis in the State of São Paulo, Brazil--epidemiology in transformation. Ann Agric Environ Med 1998 0.79
106 Value of cytogenetics in the differential diagnosis of the small round cell tumors of childhood. Med Pediatr Oncol 1992 0.79
107 Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia. Leukemia 2012 0.79
108 Rhabdomyosarcoma with primary osteolytic lesions simulating non-Hodgkin's lymphoma. Pediatr Hematol Oncol 1991 0.79
109 Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7). Genes Chromosomes Cancer 1998 0.79
110 Distribution of TP53 mutations among acute leukemias with MLL rearrangements. Genes Chromosomes Cancer 1996 0.79
111 The c-kit receptor and its ligand stem cell factor in childhood malignant lymphoid precursors. J Interferon Cytokine Res 1999 0.79
112 Microsurgical treatment of injury to peripheral nerves in upper and lower limbs: a critical review of the last 8 years. Microsurgery 2007 0.79
113 Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int 2000 0.79
114 Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88. J Clin Oncol 1997 0.78
115 Flt-3 and its ligand are expressed in neural crest-derived tumors and promote survival and proliferation of their cell lines. Lab Invest 2001 0.78
116 Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines? J Biol Regul Homeost Agents 2003 0.78
117 Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study. Leukemia 2007 0.78
118 Cerebral lateralization in simultaneous interpretation. Brain Lang 1990 0.78
119 Active and late rosette-forming cells: immunological and cytochemical characterization. Cell Immunol 1981 0.78
120 Immunological features in chronic lymphocytic leukaemia (CLL) of T cell origin. J Clin Lab Immunol 1979 0.78
121 Peculiar allelotype associated with susceptibility to neuroblastoma. Genes Chromosomes Cancer 1996 0.78
122 Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis. Br J Cancer 2013 0.78
123 Primary intestinal lymphangiectasia. Comparison between endoscopic and radiological findings. Helv Paediatr Acta 1980 0.78
124 Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia. Leukemia 2006 0.78
125 The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia. Leuk Res 1997 0.78
126 Low prevalence of IDH1 gene mutation in childhood AML in Italy. Leukemia 2010 0.78
127 Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome. Leuk Res 1996 0.78
128 Cytogenetics of infantile leukemias and its correlations with bio-clinical features. The "G. Gaslini" Children's Hospital experience over a 9-year period. Haematologica 1991 0.78
129 ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises. Br J Haematol 1990 0.77
130 Cytogenetics of pediatric central nervous system tumors. Cancer Genet Cytogenet 1996 0.77
131 Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin. Kidney Int 1996 0.77
132 Induction of apoptosis in Jurkat cells by photoexcited psoralen derivatives: Implication of mitochondrial dysfunctions and caspases activation. Toxicol In Vitro 2006 0.77
133 T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy. Leukemia 2006 0.77
134 Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Hepatology 1998 0.77
135 Latent hepatitis B virus infection in childhood hepatocellular carcinoma. Analysis by polymerase chain reaction. Cancer 1992 0.77
136 Centralized cytogenetic analysis of pediatric acute leukemia: results of an Italian collaborative experience. Haematologica 1998 0.77
137 Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? Cancer Genet Cytogenet 1992 0.77
138 Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin. Arzneimittelforschung 1998 0.77
139 Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies. Cancer 1993 0.77
140 Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. Bone Marrow Transplant 1998 0.77
141 Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia 2003 0.77
142 P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9. Br J Haematol 1996 0.77
143 Rapid detection of clonality in patients with acute lymphoblastic leukemia. Haematologica 2001 0.77
144 Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica 1998 0.76
145 Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements. Leukemia 2004 0.76
146 Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia. Br J Cancer 1994 0.76
147 Rare frequencey of point mutations for codon 12, 13 and 61 of ras gene in italian neuroblastoma. Int J Oncol 1993 0.76
148 Fluorescence in situ hybridization improves cytogenetic results in the analysis of hepatoblastoma. Cancer Genet Cytogenet 2002 0.76
149 Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology. Liver 1998 0.75
150 Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification. Exp Hematol 1987 0.75
151 Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study. Haematologica 2001 0.75
152 Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia 1994 0.75
153 Study of cytochemical markers ACP and ANAE in childhood lymphoma and leukaemia. Br J Cancer 1980 0.75
154 Lymphocyte phenotype after treatment for leukemia. Blood 1990 0.75
155 Prognostic relevance of cell proliferative rapidity in neoplastic hemo-lymphopathology. Exp Hematol 1997 0.75
156 Reply to van der Sluijs-Gelling et al. Leukemia 2005 0.75
157 Congenital hypoplastic anaemia developed in acute megakarioblastic leukaemia. A case report. Helv Paediatr Acta 1981 0.75
158 Warts and cervical cancer. Br Med J (Clin Res Ed) 1984 0.75
159 [Multinodular hepatic hemangioendothelioma in infancy. Description of 4 cases]. Minerva Pediatr 1979 0.75
160 [Diphtheria--tetanus--pertussis]. Pediatr Med Chir 1995 0.75
161 Is the deletion of the short arm of chromosome 1 a prognostic factor in pediatric peripheral primitive neuroepithelioma (PNET)? Med Pediatr Oncol 1996 0.75
162 [Heparinemia and atheroslerosis. Pentosan sulfuropolyester analysis in atherosclerotic dyslipemias]. Prensa Med Argent 1967 0.75
163 Does hepatitis B virus play a role in primary liver cancer in children of Western countries? Cancer Detect Prev 1991 0.75
164 Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin. Eur J Haematol 1987 0.75
165 [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]. Pediatr Med Chir 1994 0.75
166 Cytokeratins patterns in childhood primary liver tumors. Int J Clin Lab Res 1993 0.75
167 Characterization of two patients with lymphomas of large granular lymphocytes. Cancer 1984 0.75
168 Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia. Haematologica 1998 0.75
169 [Resporatory variations of Well's index]. Rev Clin Esp 1971 0.75
170 [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl]. Prensa Med Argent 1970 0.75
171 Renal immunohistochemical distribution, plasma levels and urinary excretion of endothelin after kidney transplantation. J Nephrol 1998 0.75
172 Unique genotypic features of infant acute lymphoblastic leukaemia at presentation and at relapse. Br J Haematol 1992 0.75
173 N-acetyl-beta-D-glucosaminidase activity in T chronic lymphocytic leukaemia. Acta Haematol 1981 0.75
174 Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors. Eur J Histochem 1997 0.75
175 Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia. Leuk Res 1995 0.75
176 Hairy cell leukaemia with T cell features. Br J Haematol 1980 0.75
177 Fluorescent in situ hybridization (FISH) reveals frequent and recurrent numerical and structural abnormalities in hepatoblastoma with no informative karyotype. Med Pediatr Oncol 2002 0.75
178 Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation. Leukemia 2007 0.75
179 The guanine triphosphatase (GTPase) activating protein (GAP)-related domain of the neurofibromatosis type 1 gene is not mutated in neural crest-derived sporadic tumours. Eur J Cancer 1998 0.75
180 Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP). Eur J Cancer 1993 0.75
181 Interleukin-2 before and/or after autologous bone marrow transplantation for pediatric acute leukemia patients. Bone Marrow Transplant 1996 0.75
182 Karyotype evolution in a patient with biphenotypic neonatal leukemia. Cancer Genet Cytogenet 1992 0.75
183 [Cerebral changes shown by computed tomography in children with acute lymphatic leukemia after therapy]. Radiol Med 1984 0.75
184 Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin. Haematologica 1999 0.75
185 Immunocytochemical evidence of common-ALL antigen in null-ALL. Scand J Haematol 1985 0.75
186 A case of juvenile myelomonocytic leukemia presenting with a B-lymphoblastic immunophenotype. Haematologica 2001 0.75
187 D cells with cytotoxic activity in acute lymphoblastic leukemia. Clin Immunol Immunopathol 1980 0.75
188 [Etiologic diagnosis of pneumonia in the immunocompromised child]. G Ital Chemioter 1995 0.75
189 Unusual leukemic presentation of rhabdomyosarcoma: report of two cases with immunological, ultrastructural and cytogenetical studies. Haematologica 1992 0.75
190 Immunological and cytochemical characterization of normal and neoplastic human T-lymphocytes. Haematologica 1979 0.75
191 Can primary cancer of the liver in Western countries be prevented? Pediatric point of view. Med Pediatr Oncol 1990 0.75
192 Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression. Haematologica 1993 0.75
193 Coordinate frames for naming misoriented chimerics: a case study of visuo-spatial neglect. Cortex 1995 0.75
194 Molecular characterization of Ph' + hybrid acute leukemia. Leuk Res 1989 0.75
195 Cytochemical study in human lymphocyte subpopulations as defined by Fc receptors. Thymus 1981 0.75
196 Significance of serial biopsies after renal allograft in children. Transplant Proc 1998 0.75
197 [The value of color Doppler studies to conventional cardiac Doppler studies]. Schweiz Rundsch Med Prax 1989 0.75
198 Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients. Eur J Cancer 1997 0.75
199 Non-T, non-B childhood acute lymphoblastic leukemia. Correlation between cytochemical markers and first complete remission. Cancer 1984 0.75
200 Improvement of the accuracy of noise measurements by the two-amplifier correlation method. Rev Sci Instrum 2013 0.75
201 Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias". Haematologica 1992 0.75